Advanced Lung Cancer with EGFR Mutation Positive Adenocarcinoma

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

  • $ 645
  • Industry report
  • by Firstword Pharma
  • Oct 2014

The potential blockbuster status of Novartis' LCZ696 has seemingly been cemented in the eyes of the Street thanks to solid results from the Phase III PARADIGM-HF study that were presented over the weekend. Indeed, the chronic heart failure agent is believed to represent both a significant growth drive ...

Industries: Pathology | Countries: United States

Payer Insights: Hepatitis C

Payer Insights: Hepatitis C

  • $ 6 495
  • Industry report
  • by Firstword Pharma
  • September 2014

The race is on for the company that can competitively price treatment regimens, share data on clinical benefit/positioning and support patient initiatives. Payer Insights: Hepatitis C, based on in-depth interviews with 12 leading healthcare payers in the US, is packed with hard-hitting, candid opinions ...

Industries: Pathology | Countries: United States

Genzyme Corporation (Symbol:GENZ) SWOT Analysis, Strategy, Revenues and Profits

Genzyme Corporation (Symbol:GENZ) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • September 2014
  • 43 pages

Genzyme Corporation (Genzyme) is a biotechnology company which is principally engaged in developing and applying technologies in the life sciences to encounter unmet deadly diseases. Its products and services are focused on rare genetic disorders, kidney diseases, orthopedics, organ transplant, cancer, ...

Industries: Pathology | Countries: United States

Agenus, Inc. (Symbol:AGEN) SWOT Analysis, Strategy, Revenues and Profits

Agenus, Inc. (Symbol:AGEN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • September 2014
  • 47 pages

Agenus Inc (Agenus), formerly known as Antigenics, Inc., is a biotechnology company engaged in the development of superior health care products and technologies to treat various forms of cancers, infectious diseases and autoimmune disorders based on immunological approaches. The company is focused on ...

Industries: Pathology | Countries: United States

Post Menopausal Osteoporosis - Pipeline Review, H2 2014

Post Menopausal Osteoporosis - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • September 2014
  • 80 pages

Post Menopausal Osteoporosis - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Post Menopausal Osteoporosis - Pipeline Review, H2 2014', provides an overview of the Post Menopausal Osteoporosis's therapeutic pipeline. This report provides comprehensive information on the therapeutic development ...

Industries: Pathology | Countries: World, Finland, United States

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • September 2014
  • 192 pages

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014', provides an overview of the Refractory Chronic Lymphocytic Leukemia (CLL)'s therapeutic pipeline. This report provides ...

Industries: Pathology | Countries: United States, World

Banyan Biomarkers, Inc. - Product Pipeline Analysis, 2014 Update

Banyan Biomarkers, Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • by Global Data
  • September 2014
  • 35 pages

Summary Banyan Biomarkers, Inc. (Banyan) is a diagnostic company. The company research and develops in vitro diagnostic products to detect traumatic brain injuries. Its services include therapies for organ injury such as traumatic brain injuries. The company's research programs concentrates in the areas ...

Industries: Pathology | Countries: United States

Civatech Oncology Inc. - Product Pipeline Analysis, 2014 Update

Civatech Oncology Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • by Global Data
  • September 2014
  • 19 pages

Summary Civatech Oncology Inc. (Civatech) is a medical device company. The company develops novel polymer based devices for the treatment of cancer using localized, low-dose-rate radiation. Its products include CivaString LDR source and CivaSheet LDR source. Its CivaTech LDR source is a uni-directional ...

Industries: Pathology | Countries: United States

Insightra Medical Inc. - Product Pipeline Analysis, 2014 Update

Insightra Medical Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • by Global Data
  • September 2014
  • 23 pages

Summary Insightra Medical Inc. (Insightra Medical) is a medical device company. The company manufactures medical devices in the areas of cardiology, surgery, endoscopy, and urology. It offers products such as the freedom inguinal hernia repair system, the freedom ventral hernia repair system, the modulare ...

Industries: Pathology | Countries: United States

Chronix Biomedical, Inc. - Product Pipeline Analysis, 2014 Update

Chronix Biomedical, Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • by Global Data
  • September 2014
  • 41 pages

Summary Chronix Biomedical, Inc. (Chronix Biomedical) is a molecular diagnostic company. The company develops blood tests for monitoring minimal residual disease in cancer patients. It develops test kits that are used for the detection and monitoring of chronic diseases in human beings and animals. Chronix ...

Industries: Pathology | Countries: United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.